Tim Hendrikx is an expert in Hepatology at Medical University of Vienna (Austria). Tim Hendrikx has authored 68 publications, the most recent in 2026. SLR score: 245 (community average: 125). How the SLR is computed.

LeadR Profile

Tim Hendrikx Medical University of Vienna Austria
245 ScienceLeadR Reputation 245
Network Map

Hepatology

Subspecialties: Gastroenterology - Biochemistry - Immunology

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Expert Rankings

Top experts on the MeSH terms this expert works on

Organizations

Career arc: 2010 - 2026

Source: PubMed

Medical University of Vienna

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 68

Citations

Citations: 2 257 1st author: 17 Last author: 11 Unique author: 0


Best Journals

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Alcohol intake reprograms hepatic immune-metabolic circuits to exacerbate murine atherosclerosis and human cardiovascular risk.
PMID 42320622 — liver diseases, hyperuricemia, uric acid, cardiovascular diseases, dyslipidemias, inflammasomes, liver, diet, atherosclerosis, ethanol, alcohol drinking
JHEP Rep20261
Bridging discovery and clinical science: A framework for advancing atherosclerosis research using innovative models.
PMID 42177118 — cells, microscopy, electron, scanning transmission, multiple chronic conditions, biomarkers, research, atherosclerosis, therapeutics, artificial intelligence
Atherosclerosis20260
Single-nucleus profiling reveals hepatocyte identity and immune features associated with corticosteroid response in severe alcohol-related hepatitis.
PMID 42019631 — liver diseases, hepatocytes, mortality, adrenal cortex hormones, biopsy, liver, therapeutics, hepatitis, non-responder
J Hepatol Top journal20260
TNFα is a trigger of aging-associated liver inflammation in mice.
PMID 41530146 — fibrosis, aging, liver, tissues, microbiota
NPJ Aging20260
IgM Antibodies Targeting Malondialdehyde Promote Complement-Mediated Liver Injury in Alcohol-Related Liver Disease.
PMID 40960284 — liver diseases, cells, bone marrow, serum, antibodies, bone marrow transplantation, immunoglobulins, liver, complement c3, malondialdehyde, complement system proteins, ethanol, transplantation
Liver Int20250

LeadR Networks

Main global connection map